WO2009066181A3 - Oral delayed-release duloxentine hydrochloride pellets - Google Patents
Oral delayed-release duloxentine hydrochloride pellets Download PDFInfo
- Publication number
- WO2009066181A3 WO2009066181A3 PCT/IB2008/003741 IB2008003741W WO2009066181A3 WO 2009066181 A3 WO2009066181 A3 WO 2009066181A3 IB 2008003741 W IB2008003741 W IB 2008003741W WO 2009066181 A3 WO2009066181 A3 WO 2009066181A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- duloxentine
- release
- oral delayed
- hydrochloride pellets
- pellets
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Abstract
The invention relates to oral delay ed-re lease pellets of duloxetine hydrochloride. The invention further includes processes for their preparation and utilization.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US92969707P | 2007-07-09 | 2007-07-09 | |
US60/929,697 | 2007-07-09 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2009066181A2 WO2009066181A2 (en) | 2009-05-28 |
WO2009066181A3 true WO2009066181A3 (en) | 2009-08-20 |
Family
ID=40667910
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2008/003741 WO2009066181A2 (en) | 2007-07-09 | 2008-07-09 | Oral delayed-release duloxentine hydrochloride pellets |
Country Status (2)
Country | Link |
---|---|
AR (1) | AR067502A1 (en) |
WO (1) | WO2009066181A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2376095B1 (en) * | 2008-10-02 | 2013-01-24 | Laboratorios Del Dr. Esteve, S.A. | ENERGY PELLETS OF DULOXETINE. |
MX2012003082A (en) * | 2009-09-17 | 2012-04-19 | Cadila Healthcare Ltd | Pharmaceutical compositions for reducing alcohol-induced dose dumping. |
PL224543B1 (en) | 2013-08-21 | 2017-01-31 | Pabianickie Zakłady Farm Polfa Spółka Akcyjna | Duloxetine enteric tablet |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0693282A2 (en) * | 1994-07-18 | 1996-01-24 | Eli Lilly And Company | Duloxetine enteric pellets |
WO1997033880A1 (en) * | 1996-03-11 | 1997-09-18 | Eli Lilly And Company | Methods of treating or preventing interstitial cystitis |
EP1640000A2 (en) * | 2002-11-27 | 2006-03-29 | Boehringer Ingelheim International GmbH | Pharmaceutical composition comprising a beta-3-adrenoceptor agonist and a serotonin and/or norepinephrine reuptake inhibitor |
WO2007034503A2 (en) * | 2005-06-20 | 2007-03-29 | Cadila Healthcare Limited | Controlled release dosage formulation of duloxetine |
WO2007139886A2 (en) * | 2006-05-22 | 2007-12-06 | Teva Pharmaceutical Industries Ltd. | Duloxetine hydrochloride delayed release formulations |
EP1938840A1 (en) * | 2006-12-27 | 2008-07-02 | LEK Pharmaceuticals D.D. | Duloxetine composition |
WO2008129501A2 (en) * | 2007-04-20 | 2008-10-30 | Wockhardt Research Centre | Pharmaceutical compositions of duloxetine |
-
2008
- 2008-07-09 WO PCT/IB2008/003741 patent/WO2009066181A2/en active Application Filing
- 2008-07-10 AR ARP080102970A patent/AR067502A1/en unknown
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0693282A2 (en) * | 1994-07-18 | 1996-01-24 | Eli Lilly And Company | Duloxetine enteric pellets |
WO1997033880A1 (en) * | 1996-03-11 | 1997-09-18 | Eli Lilly And Company | Methods of treating or preventing interstitial cystitis |
EP1640000A2 (en) * | 2002-11-27 | 2006-03-29 | Boehringer Ingelheim International GmbH | Pharmaceutical composition comprising a beta-3-adrenoceptor agonist and a serotonin and/or norepinephrine reuptake inhibitor |
WO2007034503A2 (en) * | 2005-06-20 | 2007-03-29 | Cadila Healthcare Limited | Controlled release dosage formulation of duloxetine |
WO2007139886A2 (en) * | 2006-05-22 | 2007-12-06 | Teva Pharmaceutical Industries Ltd. | Duloxetine hydrochloride delayed release formulations |
EP1938840A1 (en) * | 2006-12-27 | 2008-07-02 | LEK Pharmaceuticals D.D. | Duloxetine composition |
WO2008129501A2 (en) * | 2007-04-20 | 2008-10-30 | Wockhardt Research Centre | Pharmaceutical compositions of duloxetine |
Non-Patent Citations (1)
Title |
---|
JANSEN P J ET AL: "CHARACTERIZATION OF IMPURITIES FORMED BY INTERACTION OF DULOXETINE HCI WITH ENTERIC POLYMERS HYDROXYPROPYL METHYLCELLULOSE ACETATE SUCCINATE AND HYDROXYPROPYL METHYLCELLULOSE PHTHALATE", JOURNAL OF PHARMACEUTICAL SCIENCE, AMERICAN PHARMACEUTICAL ASSOCIATION, WASHINGTON, US, vol. 87, no. 1, 1 January 1998 (1998-01-01), pages 81 - 85, XP000891949, ISSN: 0022-3549 * |
Also Published As
Publication number | Publication date |
---|---|
WO2009066181A2 (en) | 2009-05-28 |
AR067502A1 (en) | 2009-10-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2009066326A3 (en) | Improved process for the preparation of prasugrel and its pharmaceutically acceptable salts | |
IL194877A0 (en) | Duloxetine hydrochloride delayed release formulations | |
HK1141013A1 (en) | Process for the preparation of certain substituted sulfilimines | |
EP2043136A4 (en) | Film-forming composition | |
IL210549A (en) | Substituted- quinoxaline-type bridged-piperidine compounds, compositions comprising them and uses thereof for the manufacture of medicaments | |
EP2240173A4 (en) | Delayed release pharmaceutical composition of duloxetine | |
WO2010056656A3 (en) | Preparation of crystalline palonosetron hydrochloride | |
WO2008129501A3 (en) | Pharmaceutical compositions of duloxetine | |
WO2010129636A3 (en) | Lenalidomide polymorph | |
WO2010065586A3 (en) | Preparation of capecitabine | |
WO2012075015A3 (en) | Oral metronidazole pharmaceutical compositions | |
PT2229062E (en) | A process for the preparation of a hydrolysate | |
WO2010006904A3 (en) | Crystalline forms of rabeprazole sodium | |
WO2010015656A3 (en) | Alkoxypyrazoles and the process for their preparation | |
EP2051731A4 (en) | Methods for reducing the incidence of mastitis | |
GB0910201D0 (en) | The preparation method of 2-deoxy-l-ribose | |
WO2011023954A3 (en) | Polymorphic forms of manidipine | |
ZA200808011B (en) | Process for the isolation of calliterpenone (16alpha, 17-DiHyDroxy-S-Oxo-Phyllocladane) | |
ZA200901083B (en) | Modified release pharmaceutical composition of bupropion hydrochloride | |
SI2044099T1 (en) | Process for the preparation of s-fluoromethyl-6 ,9 -difluoro-11 -hydroxy-16 -methyl-17 -propionyloxy-3-oxo-androsta-1,4-diene-17 -carbothioate and intermediates | |
HUP0700756A2 (en) | Process for the preparation of pharmaceutical intermediers | |
EP2083003A4 (en) | Process for preparation of 1,1,1,3,3-pentachlorobutane | |
WO2009066181A3 (en) | Oral delayed-release duloxentine hydrochloride pellets | |
IL211062A0 (en) | Pharmaceutical uses of lanosta-8,24-dien-3-ols | |
EP2111285B8 (en) | A method for the preparation of a reducing agent composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 08851213 Country of ref document: EP Kind code of ref document: A2 |